Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma
NCT00256880
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Renal Cell
Interventions
DRUG:
GW786034
Sponsor
GlaxoSmithKline